Sterile IV containers market seen topping $10.6 billion by 2030

The sterile IV containers market is projected to grow from $6.36 billion in 2025 to $7.06 billion in 2026, with North America remaining the largest regional market. The Business Research Company says rising home healthcare use, infection-control demands and chronic disease care are helping push the market toward $10.61 billion by 2030.

Why it matters: - Sterile IV containers are a core part of safe intravenous treatment in hospitals, clinics and home healthcare. - Market growth points to rising demand for infection-safe fluid and drug delivery as care shifts more into outpatient and home settings. - The market is forecast to reach $10.61 billion by 2030, signaling continued expansion in a category tied to patient safety and treatment access.

What happened: - The Business Research Company said the sterile IV containers market will grow from $6.36 billion in 2025 to $7.06 billion in 2026. - The forecast implies a 11.1% compound annual growth rate in 2026. - The market is expected to expand at a 10.7% CAGR to $10.61 billion by 2030. - North America held the largest regional market share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - The market’s historical growth has been driven by higher hospital admission rates, greater use of intravenous therapy, stricter infection control protocols, stronger pharmaceutical demand and expansion in emergency care services. - The report points to ambulatory care centers, sustainability, higher demand for intravenous drug administration, chronic disease prevalence and healthcare infrastructure development as drivers of future growth. - Key trends include a shift toward non-PVC IV containers, more pre-filled IV solutions, stronger infection-prevention efforts, more hospital and clinic expansion and customizable IV packaging. - Sterile intravenous containers are designed to safely hold IV fluids and medications for direct administration into the bloodstream. - The containers undergo sterilization to remove contaminants such as bacteria and pathogens. - The report says sterility is essential for patient safety in hospitals, clinics and home healthcare settings. - A free sample of the report is available through the company’s sample page. - The full report is available through the company’s report page.

Between the lines: - Home healthcare is emerging as a major demand driver because more patients are receiving long-term treatment outside traditional hospital settings. - The report links that shift to aging populations and ongoing chronic illness management, both of which increase reliance on sterile infusion products. - CMS reported in December 2024 that U.S. spending on services provided by freestanding home health care agencies rose 10.8% in 2023 to $147.8 billion, up 6.7% from 2022. - The market report’s added scoring tools and forecasting dashboards suggest the industry is being tracked as a data-heavy category with multiple growth pockets.

What’s next: - Growth is likely to track continued expansion in home healthcare, ambulatory care and chronic disease treatment. - Non-PVC materials, pre-filled solutions and customizable packaging may gain more traction as manufacturers respond to sustainability and infection-control pressures. - The market’s regional leadership could shift over time if healthcare infrastructure investment accelerates outside North America.

The bottom line: - Sterile IV containers are moving from a steady medical supply niche into a faster-growing market shaped by home care, infection control and broader shifts in how intravenous treatment is delivered.